Market Place
Sourcing Support
Alloy Partners with Takeda on iPSC-Derived Cell Therapies
20 Nov 2024 //
CONTRACTPHARMA
Alloy Therapeutics Licenses ATX-Gx™ Platform from Scripps Research
30 Oct 2024 //
BUSINESSWIRE
Alloy Therapeutics Announces Platform License Agreement with Lilly
21 May 2024 //
BUSINESSWIRE
Lyra to lay off 75% of its workers; Dupixent nears COPD decision
21 May 2024 //
ENDPTS
Mission Bio Launches 2024 Platinum Program With Lilly, Ono, Alloy
01 May 2024 //
PR NEWSWIRE
Alloy Announces Board to Drive Roadmap of Biotherapeutic Discovery Platform
20 Sep 2023 //
BUSINESSWIRE
Alloy Expands Executive Team to Discovery & Innovation for Its Partners
29 Jun 2023 //
BUSINESSWIRE
Alloy to Empower Drug Discovery of Lundbeck’s Biologics for Brain Health
02 May 2023 //
BUSINESSWIRE
Alloy Unveils 2023 Innovation Roadmap Across Antibodies & Genetic Medicines
09 Jan 2023 //
BUSINESSWIRE
Alloy Therapeutics and Normunity Sign Antibody Discovery Collaboration
17 Nov 2022 //
BUSINESSWIRE
Alloy Therapeutics Raises $42 Million Series D Financing
03 Oct 2022 //
BUSINESSWIRE
Alloy Hires People Executive Trier Bryant as President of Venture Studio, 82VS
07 Sep 2022 //
BUSINESSWIRE
Alloy Tx Offerings Go Intracellular Through Collaboration in Genetic Medicines
09 Jun 2022 //
BUSINESSWIRE
Tegmine Tx, Alloy Tx Collaborate to Advance Solid Tumor Treatment
06 Apr 2022 //
BUSINESSWIRE
Alloy Therapeutics Acquires deepCDR Biologics
09 Dec 2021 //
BUSINESSWIRE
Alloy Therapeutics, Echo Investment Capital Create Wheeler Bio
27 Jul 2021 //
CONTRACT PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.